Antileishmanial activity of sodium stibogluconate fractions.
Sodium stibogluconate, a pentavalent antimony derivative produced by the reaction of stibonic and gluconic acids, is the drug of choice for the treatment of leishmaniasis. It has been reported to be a complex mixture rather than a single compound. We separated sodium stibogluconate into 12 fractions...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1993
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188079/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8239593/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.9.1842 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|